Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products

International Journal of Pharmaceutics
B Van EerdenbrughP Augustijns

Abstract

During the last 10-15 years, the formulation of drugs as nanocrystals has rapidly evolved into a mature drug delivery strategy, with currently five products on the market. The major characteristic of these systems is the rapid dissolution velocity, enabling bioavailability enhancement after oral administration. This mini-review focuses on recent advances with respect to three topics considering drug nanocrystals. The first topic is nanosuspension stabilization. A current literature status is provided and special attention is given to studies attempting to extend our physicochemical understanding of the underlying principles. The second part describes recent advances on miniaturization of nanosuspension production, to enable formulation screening during preclinical development. Finally, literature available on further nanosuspensions solidification is discussed, focussing on the maintenance of the preservation of the rapid dissolution properties of the nanocrystals after further downstream processing.

References

Dec 28, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·K D OstranderD M Bondanza
Mar 4, 2000·International Journal of Pharmaceutics·M J GrauR H Müller
May 17, 2001·Antimicrobial Agents and Chemotherapy·N SchölerO Liesenfeld
Apr 17, 2002·International Journal of Pharmaceutics·R H Müller, C Jacobs
Jun 14, 2002·International Journal of Pharmaceutics·G J VergoteJ P Remon
Oct 31, 2002·Angewandte Chemie·Dieter Horn, Jens Rieger
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Mar 5, 2003·International Journal of Pharmaceutics·O KayserS L Croft
Sep 23, 2003·Journal of Pharmaceutical Sciences·Jonghwi Lee
Apr 28, 2004·Drug Development and Industrial Pharmacy·Jiahui HuRobert O Williams
Jul 6, 2004·The Journal of Pharmacy and Pharmacology·V B PatravaleR M Kulkarni
Sep 2, 2004·Nature Reviews. Drug Discovery·Barrett E Rabinow
Sep 29, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jan MöschwitzerRainer H Müller
Oct 23, 2004·Pharmaceutical Research·Elaine Merisko-LiversidgeGary G Liversidge
Nov 3, 2004·Nature Reviews. Drug Discovery·Colin R GardnerOrn Almarsson
Feb 4, 2005·Nature Materials·Christian Joachim
Mar 24, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jonghwi LeeCheol-Hee Ahn
Apr 16, 2005·Drug Development and Industrial Pharmacy·P LangguthH Spahn-Langguth
Dec 8, 2005·Journal of Drug Targeting·Norma Hernández-TrejoRainer H Müller
Dec 27, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jan Möschwitzer, Rainer H Müller
Jan 18, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun-ichi JinnoToshikiro Kimura
Jan 25, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jonghwi Lee, Yu Cheng
Jul 19, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J HecqK Amighi
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Matthew Todd CrispKeith P Johnston
Mar 27, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kalle SigfridssonJennie de Verdier
Apr 3, 2007·International Journal of Pharmaceutics·Barrett RabinowKristy Wood
Jun 30, 2007·International Journal of Pharmaceutics·M A KassemR M Khalil
Jul 3, 2007·Advanced Drug Delivery Reviews·Filippos KesisoglouYunhui Wu
Oct 9, 2007·International Journal of Pharmaceutics·Ruolan XiongTingting Chen
Dec 21, 2007·International Journal of Pharmaceutics·Z DengS Li
Feb 5, 2008·International Journal of Pharmaceutics·Lei GaoWenfa Zhao
Feb 12, 2008·International Journal of Pharmaceutics·J LeeC H Park
Jul 8, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Bernard Van EerdenbrughPatrick Augustijns
Jul 23, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bernard Van EerdenbrughGuy Van den Mooter

❮ Previous
Next ❯

Citations

Feb 10, 2010·Pharmaceutical Research·Francis IgnatiousJohn Baldoni
Apr 23, 2013·Colloids and Surfaces. B, Biointerfaces·Pradum Pundlikrao IgeSurendra G Gattani
Apr 17, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jaime SalazarJan P Möschwitzer
Sep 4, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Annika SarnesLeena Peltonen
Jun 12, 2013·International Journal of Pharmaceutics·Chris Brough, R O Williams
Oct 24, 2013·International Journal of Pharmaceutics·Biswadip SinhaJan P Möschwitzer
Jan 2, 2013·Chemical Reviews·Venkat Ratnam DevadasuM N V Ravi Kumar
Feb 3, 2012·ACS Nano·Kathrin FuhrmannJean-Christophe Leroux
Oct 6, 2011·Anti-cancer Drugs·Meghna TalekarSanjay Garg
Sep 10, 2011·International Journal of Nanomedicine·Qi TanGuangxi Zhai
Jul 18, 2012·International Journal of Nanomedicine·Doaa M RagabStyliani Consta
Aug 27, 2013·International Journal of Nanomedicine·Peng-Fei YueHai-Long Yuan
Jun 28, 2014·International Journal of Nanomedicine·Ibrahim ElsayedAhmed Hassen Elshafeey
Jan 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying LuMichael Sturek
Mar 29, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vivek K PawarManish K Chourasia
Dec 18, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Lijiang ChenDianrui Zhang
May 13, 2014·International Journal of Pharmaceutics·Xuezhen ZhaiRainer H Müller
Jan 7, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Lieselotte De SmetJean Paul Remon
Aug 16, 2014·International Journal of Pharmaceutical Investigation·Kiran ThadkalaJithan Aukunuru
Nov 8, 2013·European Journal of Drug Metabolism and Pharmacokinetics·Bhanu P Sahu, Malay K Das
Apr 26, 2013·AAPS PharmSciTech·Peng LiuTimo Laaksonen
Sep 1, 2014·International Journal of Pharmaceutics·Jun ZhangZafar Iqbal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Drug Discovery
Barrett E Rabinow
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Cornelia M Keck, Rainer H Müller
© 2022 Meta ULC. All rights reserved